Healthcare -
Biotechnology - NASDAQ - US
$ 6.45
-4.02 %
$ 143 M
Market Cap
-2.96
P/E
INMB - OPERATING INCOME
Operating Income INMB - INmune Bio, Inc.
-29.7 M
LAST VALUE
-1.00%
2 YEAR CAGR
-19.04%
5 YEAR CAGR
0.00%
10 YEAR CAGR